findmyKOL
Clinical trialNCT07580898RecruitingPhase 1Interventional

Safety of MOON101 for the Treatment of Peanut Allergy

SponsorMoonlight Therapeutics, Inc.Enrollment40Peanut Allergy
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The goal of this open-label, single escalating dose study in 3 sequential groups: adults, adolescents, and children with peanut allergy is to assess the safety of MOON101. The main question it aims to answer is: 1. the incidence and frequency of all treatment emergent adverse events (TEAEs) from baseline through study exit. 2. to determine the highest tolerated dose for each participant, as defined by the highest MOON101 dose level administered which did not cause a dose-limiting symptom (DLS). The study will compare MOON101 and placebo. All participants will receive both active MOON101 (peanut allergen) and placebo (no peanut allergen).
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Arkansas Children'S Research Institute

    Little Rock, Arkansas, United States

    Recruiting
  • Children'S Healthcare of Atlanta

    Atlanta, Georgia, United States

    Recruiting
  • Dr. Vince Clinical Research

    Overland Park, Kansas, United States

    Recruiting
  • University of Michigan

    Ann Arbor, Michigan, United States

    Recruiting
  • University of North Carolina at Chapel Hill

    Chapel Hill, North Carolina, United States

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
29 Jun 2026
Primary completion
31 Dec 2027
Completion
31 Dec 2027
Last update posted
14 Jul 2026
Registered enrollment
40
Registry id
NCT07580898
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.